Experts at CHEST 2024 highlighted significant racial disparities in lung cancer screening, treatment, and outcomes, ...

The updated guidelines from the US Preventive Services Task Force (USPSTF) have led to an increase in screening for ...

Hereditary breast cancers are caused by germline mutations, which are genetic mutations inherited at conception and so called ...

Experts at the CHEST 2024 annual meeting agreed that artificial intelligence (AI) should not be relied upon entirely, but ...

Blue Shield of California will offer an adalimumab biosimilar at a price that is 75% less than the reference product Humira ...

Less than a third of FDA-mandated trials for drugs approved between 2015 and 2021 had been completed by May 2024.

One of the first sessions to kick off CHEST 2024 in Boston looked at the future of physician compensation, which highlighted ...

Key opinion leaders explore educational initiatives aimed at enhancing guideline adherence in cardiometabolic risk management ...

Krunal Patel, MD, Temple University Hospital, highlights CHEST 2024 data revealing why timing matters with acute pulmonary embolism (PE) intervention.

Medical experts examine strategies for care coordination in high-risk patients with cardiometabolic conditions.

In this interview, Juan Carlos Martinez, MD, explains that while patients recognize the severity of lung cancer, there is a lack of knowledge about lung cancer screening methods, likely due to ...